To examine the effect of Dex on GR-overexpressing lung adenocarcinoma tumors in vivo, we first used isogenic tumor xenografts derived from parental H1299 (low GR) cells and H1299GR Clone 4 (high GR) cells. This evidence concerns the gene NR3C1 and lung adenocarcinoma.